This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chung, J.-Y. Articles by Zheng, J. Search for Related Content PubMed PubMed Citation Articles by Chung, J.-Y. Articles by Zheng, J.

Differential Expression of Vascular Endothelial Growth Factor (VEGF), Endocrine Gland Derived-VEGF, and VEGF Receptors in Human Placentas from Normal and Preeclamptic Pregnancies

Departments of Obstetrics and Gynecology, Perinatal Research Laboratories (J.-Y.C., Y.S., R.R.M., J.Z.), Pediatrics (R.R.M.), and Animal Sciences (R.R.M.), University of Wisconsin, Madison, Wisconsin 53715; and Department of Obstetrics and Gynecology (Y.W.), Louisiana State University Medical Center, Shreveport, Louisiana 71130

Address all correspondence and requests for reprints to: Jing Zheng, Ph.D., Department of Obstetrics and Gynecology, University of Wisconsin-Madison, Perinatal Research Laboratories, 7E Meriter Hospital, 202 South Park Street, Madison, Wisconsin 53715. E-mail: jzheng{at}wisc.edu.

Vascular endothelial growth factor (VEGF) is a potent regulator of placental vascular function. Endothelial dysfunction is a key factor associated with preeclampsia. In this study, we examined expression of VEGF, endocrine gland-derived VEGF (EG-VEGF), VEGF receptors 1 and 2 (VEGFR-1 and VEGFR-2), and neuropilin-1 and -2 (NP-1 and NP-2) in human placentas from women with normal and preeclamptic (PE) pregnancies using quantitative or semiquantitative PCR. We found that total VEGF mRNA expression was increased 2.8-fold (P < 0.05), along with increases in mRNA expression of VEGF121, 165, and 189 (P < 0.05; 1.7-, 1.9-, and 1.8-fold, respectively) in PE vs. normal placentas. Expression of VEGFR-1 mRNA, but not EG-VEGF and the other three VEGF receptors studied, was elevated (P < 0.05) 2.7-fold in PE vs. normal placentas. Protein expression of VEGF and its four receptors was determined using Western blot analysis. For VEGF, two major isoforms (VEGF165 and 189) were detected. For VEGFR-1, VEGFR-2, NP-1, and NP-2, one major band was observed at 180, 235, 130, and 130 kDa, respectively. All of these bands were corresponding to their positive controls. Of these five proteins studied, only VEGFR-1 levels were increased (P < 0.05; 1.7-fold) in PE placentas. The expression of VEGF and the four VEGF receptors was confirmed using immunohistochemistry. They were primarily present in syncytiotrophoblasts and endothelial cells of villous capillaries and large vessels. Thus, together with previous reports that VEGFR-1 mediates trophoblast function and inhibits VEGF-induced angiogenesis and endothelium-dependent vasodilation, these data suggest that the increased VEGFR-1 expression may alter VEGF- mediated function on trophoblast and endothelial cells in PE placentas.

This work was supported in part by National Institutes of Health Grants HL64703 (to J.Z.), HD36822 (to Y.W.), and HL57653, HL49210, HD33255, and HD 38843 (to R.R.M.).

Abbreviations: EG-VEGF, Endocrine gland-derived VEGF; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; HUVEC, human umbilical vein endothelial cells; NP, neuropilin; PE, preeclamptic; sVEGFR-1, soluble VEGFR-1; VEGF, vascular endothelial growth factor; VEGFR, VEGF receptor.

This article has been cited by other articles:

				C. P. Thomas, J. I. Andrews, N. S. Raikwar, E. A. Kelley, F. Herse, R. Dechend, T. G. Golos, and K. Z. Liu A Recently Evolved Novel Trophoblast-Enriched Secreted Form of fms-Like Tyrosine Kinase-1 Variant Is Up-Regulated in Hypoxia and Preeclampsia J. Clin. Endocrinol. Metab., July 1, 2009; 94(7): 2524 - 2530. [Abstract] [Full Text] [PDF]

				M. Plaisier, E. Streefland, P. Koolwijk, V.W.M. van Hinsbergh, F.M. Helmerhorst, and J.J.H.M. Erwich Angiogenic Growth Factors and Their Receptors in First-Trimester Human Decidua of Pregnancies Further Complicated By Preeclampsia or Fetal Growth Restriction Reproductive Sciences, September 1, 2008; 15(7): 720 - 726. [Abstract] [PDF]

				F. C. Denison, S. Battersby, A. E. King, M. Szuber, and H. N. Jabbour Prokineticin-1: A Novel Mediator of the Inflammatory Response in Third-Trimester Human Placenta Endocrinology, July 1, 2008; 149(7): 3470 - 3477. [Abstract] [Full Text] [PDF]

				P. Brownbill, G. C. McKeeman, J. C. Brockelsby, I. P. Crocker, and C. P. Sibley Vasoactive and Permeability Effects of Vascular Endothelial Growth Factor-165 in the Term in Vitro Dually Perfused Human Placental Lobule Endocrinology, October 1, 2007; 148(10): 4734 - 4744. [Abstract] [Full Text] [PDF]

				E. Pau, I. Alonso-Muriel, R. Gomez, E. Novella, A. Ruiz, J. A. Garcia-Velasco, C. Simon, and A. Pellicer Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome Hum. Reprod., June 1, 2006; 21(6): 1453 - 1460. [Abstract] [Full Text] [PDF]

				P. Hoffmann, J.-J. Feige, and N. Alfaidy Expression and Oxygen Regulation of Endocrine Gland-Derived Vascular Endothelial Growth Factor/Prokineticin-1 and Its Receptors in Human Placenta during Early Pregnancy Endocrinology, April 1, 2006; 147(4): 1675 - 1684. [Abstract] [Full Text] [PDF]

				J. Zheng, Y. Wen, J. L. Austin, and D.-b. Chen Exogenous Nitric Oxide Stimulates Cell Proliferation via Activation of a Mitogen-Activated Protein Kinase Pathway in Ovine Fetoplacental Artery Endothelial Cells Biol Reprod, February 1, 2006; 74(2): 375 - 382. [Abstract] [Full Text] [PDF]

				E. S. W. Ngan, K. Y. Lee, W. S. B. Yeung, H. Y. S. Ngan, E. H. Y. Ng, and P. C. Ho Endocrine Gland-Derived Vascular Endothelial Growth Factor Is Expressed in Human Peri-implantation Endometrium, But Not in Endometrial Carcinoma Endocrinology, January 1, 2006; 147(1): 88 - 95. [Abstract] [Full Text] [PDF]

				O. Krysiak, A. Bretschneider, E. Zhong, J. Webb, H. Hopp, S. Verlohren, N. Fuhr, M. Lanowska, A. Nonnenmacher, R. Vetter, et al. Soluble Vascular Endothelial Growth Factor Receptor-1 (sFLT-1) Mediates Downregulation of FLT-1 and Prevents Activated Neutrophils From Women With Preeclampsia From Additional Migration by VEGF Circ. Res., December 9, 2005; 97(12): 1253 - 1261. [Abstract] [Full Text] [PDF]

				N. Soleymanlou, I. Jurisica, O. Nevo, F. Ietta, X. Zhang, S. Zamudio, M. Post, and I. Caniggia Molecular Evidence of Placental Hypoxia in Preeclampsia J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4299 - 4308. [Abstract] [Full Text] [PDF]

				L. P. Reynolds, P. P. Borowicz, K. A. Vonnahme, M. L. Johnson, A. T. Grazul-Bilska, D. A. Redmer, and J. S. Caton Placental angiogenesis in sheep models of compromised pregnancy J. Physiol., May 15, 2005; 565(1): 43 - 58. [Abstract] [Full Text] [PDF]

				K. A. Vonnahme, M. E. Wilson, Y. Li, H. L. Rupnow, T. M. Phernetton, S. P. Ford, and R. R. Magness Circulating levels of nitric oxide and vascular endothelial growth factor throughout ovine pregnancy J. Physiol., May 15, 2005; 565(1): 101 - 109. [Abstract] [Full Text] [PDF]